Phase I/II study of low-dose azacytidine in patients with chronic myeloid leukemia who have minimal residual disease while receiving therapy with tyrosine kinase inhibitors.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jorge Eduardo Cortes Hagop Kantarjian Abhishek Maiti |
| Publication date | September 23, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |